Measles, one of the world’s most contagious diseases, was declared eliminated in the US in 2000, due to widespread use of the measles-mumps-rubella vaccine.

Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use.

Recommendations focus on radiation therapy and/or adjunctive therapies for WHO grade 4 adult-type diffuse glioma.

Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.